SCPH scPharmaceuticals Inc.

3.6
+0.21  (+6%)
Previous Close 3.39
Open 3.37
Price To Book 0.95
Market Cap 66889548
Shares 18,580,430
Volume 50,585
Short Ratio
Av. Daily Volume 69,053

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 planned.
scCeftriaxone
Infections caused by gram-positive and gram-negative organisms
CRL issued June 13, 2018. Additional trials required. NDA to be refiled in 2020.
Furoscix
Heart failure
NDA filing due 2021.
Ceftriaxone
Baceteria infections